CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 140 filers reported holding CLOVIS ONCOLOGY INC in Q1 2016. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $92,000 | -83.9% | 13,700 | -84.8% | 0.34% | +10.5% |
| Q1 2020 | $573,000 | -59.7% | 90,200 | -33.9% | 0.30% | +82.6% |
| Q4 2019 | $1,423,000 | -49.0% | 136,500 | -80.8% | 0.17% | -53.2% |
| Q3 2019 | $2,788,000 | -76.8% | 709,600 | -12.3% | 0.36% | -57.2% |
| Q2 2019 | $12,033,000 | -28.0% | 809,269 | +20.2% | 0.83% | +7.9% |
| Q1 2019 | $16,706,000 | +108.9% | 673,100 | +51.2% | 0.77% | +40.3% |
| Q4 2018 | $7,997,000 | +743.6% | 445,300 | +1278.6% | 0.55% | +920.4% |
| Q3 2018 | $948,000 | -79.3% | 32,300 | -55.0% | 0.05% | -81.3% |
| Q1 2017 | $4,571,000 | +111.6% | 71,800 | -36.2% | 0.29% | +32.6% |
| Q1 2016 | $2,160,000 | -43.9% | 112,500 | +2.3% | 0.22% | -55.5% |
| Q4 2015 | $3,850,000 | +526.0% | 110,000 | +1471.4% | 0.49% | +469.8% |
| Q2 2015 | $615,000 | – | 7,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |